Diagnostic Test: Oral glucose tolerance test ( DrugBank: Glucose )

---

3 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	1
65	原発性免疫不全症候群	1
299	嚢胞性線維症	1

13. 多発性硬化症／視神経脊髄炎

---

臨床試験数 : 3,342 /  薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03052595 (ClinicalTrials.gov)	February 1, 2017	10/2/2017	Multiple Sclerosis: The Role of Mitochondrial Dysfunction in IR Resistance	Multiple Sclerosis: The Role of Mitochondrial Dysfunction in Insulin Resistance	Multiple Sclerosis;Mitochondrial Alteration	Diagnostic Test: Oral glucose tolerance test;Diagnostic Test: Testing of autonomous nervous system function;Diagnostic Test: Stroop test	Slovak Academy of Sciences	Comenius University	Recruiting	18 Years	45 Years	All	70		Slovakia

65. 原発性免疫不全症候群

---

臨床試験数 : 482 /  薬物数 : 653 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 212

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04275479 (ClinicalTrials.gov)	January 10, 2020	10/2/2020	Diabetes/ Endocrine Surveillance in SDS	Endocrine Diabetes Screening in Patients With Shwachman-Diamond Syndrome DIABETES/ ENDOCRINE SURVEILLANCE IN SDS	Shwachman-Diamond Syndrome	Diagnostic Test: Oral Glucose Tolerance Test;Other: Modified Oral Glucose Tolerance Test;Other: Modified Mixed Meal Tolerance Test;Device: Continuous Glucose Monitor;Other: Food Diary;Other: Medical History Questionnaires	Washington University School of Medicine	Shwachman Diamond Syndrome Foundation;Barnes-Jewish Hospital	Recruiting	3 Years	N/A	All	60		United States

299. 嚢胞性線維症

---

臨床試験数 : 1,696 /  薬物数 : 1,644 - (DrugBank : 272) / 標的遺伝子数 : 96 - 標的パスウェイ数 : 170

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03650712 (ClinicalTrials.gov)	July 1, 2019	18/7/2018	EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis	EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis	Cystic Fibrosis-related Diabetes	Diagnostic Test: Oral glucose tolerance test;Diagnostic Test: Continuous glucose monitoring;Diagnostic Test: Dexa scan	Katie Larson Ode	NULL	Active, not recruiting	6 Years	N/A	All	404	N/A	United States